SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ

Group 1 - Pomerantz LLP is investigating claims on behalf of investors of Johnson & Johnson regarding potential securities fraud or unlawful business practices by the company and its officers [1] - On January 8, 2025, Johnson & Johnson announced a temporary pause of the U.S. External Evaluation and all U.S. VARIPULSE™ cases due to four reported neurovascular events, leading to a stock price decline of $3.96 per share, or 2.71$142.27 [2] - Pomerantz LLP is recognized for its expertise in corporate, securities, and antitrust class litigation, having recovered numerous multimillion-dollar damages awards for victims of securities fraud and corporate misconduct [3]